The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Peripheral cannabinoid receptor, CB2, regulates bone mass
Open accessAbstract
The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid receptor type 2 (CB2). Whereas CB1 mediates the cannabinoid psychotropic, analgesic, and orectic effects, CB2 has been implicated recently in the regulation of liver fibrosis and atherosclerosis. Here we show that CB2-deficient mice have a markedly accelerated age-related trabecular bone loss and cortical expansion, although cortical thickness remains unaltered. These changes are reminiscent of human osteoporosis and may result from differential regulation of trabecular and cortical bone remodeling. The CB2–/–phenotype is also characterized by increased activity of trabecular osteoblasts (bone-forming cells), increased osteoclast (the bone-resorbing cell) number, and a markedly decreased number of diaphyseal osteoblast precursors. CB2 is expressed in osteoblasts, osteocytes, and osteoclasts. A CB2-specific agonist that does not have any psychotropic effects enhances endocortical osteoblast number and activity and restrains trabecular osteoclastogenesis, apparently by inhibiting proliferation of osteoclast precursors and receptor activator of NF-κB ligand expression in bone marrow-derived osteoblasts/stromal cells. The same agonist attenuates ovariectomy-induced bone loss and markedly stimulates cortical thickness through the respective suppression of osteoclast number and stimulation of endocortical bone formation. These results demonstrate that the endocannabinoid system is essential for the maintenance of normal bone mass by osteoblastic and osteoclastic CB2 signaling. Hence, CB2 offers a molecular target for the diagnosis and treatment of osteoporosis, the most prevalent degenerative disease in developed countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311
Hildebrand, T., Laib, A., Müller, R., Dequeker, J., & Rüegsegger, P. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1167 · Cited by 1,303
Riggs, B. L., Khosla, S., & Melton, L. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.763 · Cited by 1,143
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Self-citationFelder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
Self-citationBone strength and its determinants
Ammann, P., & Rizzoli, R. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1345-4 · Cited by 761
Genetic variability in adult bone density among inbred strains of mice
Beamer, W. G., Donahue, L. R., Rosen, C. J., & Baylink, D. J. (1996) · Bone · doi:10.1016/8756-3282(96)00047-6 · Cited by 630
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Self-citationImmunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T., Zimmer, A., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544
Self-citationVan'T Hof, R. J., & Ralston, S. H. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01261.x · Cited by 518
Temporal relationship between bone loss and increased bone turnover in ovariectomized rats
Wronski, T. J., Cintrón, M., & Dann, L. M. (1988) · Calcified Tissue International · doi:10.1007/bf02571317 · Cited by 501
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A., Frossard, J.-L., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 472
Self-citationAntifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Self-citationRegulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors
Lian, J. B., Javed, A., Zaidi, S. K., Lengner, C., Montecino, M., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.10 · Cited by 442
Calvi, L. M., Sims, N. A., Hunzelman, J. L., Knight, M. C., Giovannetti, A., Saxton, J. M., Kronenberg, H. M., Baron, R., & Schipani, E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11296 · Cited by 388
Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher, A., & Derynck, R. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.195 · Cited by 371
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Idris, A. I., van 't Hof, R. J., Greig, I. R., Ridge, S. A., Baker, D., Ross, R. A., & Ralston, S. H. (2005) · Nature Medicine · doi:10.1038/nm1255 · Cited by 356
Hypothalamic Y2 receptors regulate bone formation
Baldock, P. A., Sainsbury, A., Couzens, M., Enriquez, R. F., Thomas, G. P., Gardiner, E. M., & Herzog, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214588 · Cited by 349
Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<58::aid-glia6>3.0.co;2-w · Cited by 248
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 219
Self-citationChang, Y., Lee, S. T., & Lin, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1103 · Cited by 219
Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture.
Müller, R., & Ruegsegger, P. (1997) · PubMed · Cited by 197
Molina-Holgado, F., Pinteaux, E., Moore, J. D., Molina-Holgado, E., Guaza, C., Gibson, R. M., & Rothwell, N. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06470.2003 · Cited by 192
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
Self-citationChanging RANKL/OPG mRNA expression in differentiating murine primary osteoblasts
Thomas, G., Baker, S., Eisman, J., & Gardiner, E. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700451 · Cited by 184
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159
David, V., Laroche, N., Boudignon, B. M., Lafage‐Proust, M., Alexandre, C., Ruegsegger, P., & Vico, L. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.9.1622 · Cited by 147
Sipe, J. C., Arbour, N., Gerber, A., & Beutler, E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205111 · Cited by 139
Ross, R. A., Brockie, H. C., & Pertwee, R. G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00437-4 · Cited by 119
Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 105
Wiren, K. M., Zhang, X.-W., Toombs, A. R., Kasparcova, V., Gentile, M. A., Harada, S.-I., & Jepsen, K. J. (2004) · Endocrinology · doi:10.1210/en.2003-1016 · Cited by 81
Central IL-1 receptor signaling regulates bone growth and mass
Bajayo, A., Goshen, I., Feldman, S., CSERNUS, V. J., Iverfeldt, K., Shohami, E., Yirmiya, R., & Bab, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502562102 · Cited by 78
Self-citationCpG oligonucleotides: novel regulators of osteoclast differentiation
Zou, W., Schwartz, H., Endres, S., Hartmann, G., & Bar-Shavit, Z. (2002) · The FASEB Journal · doi:10.1096/fj.01-0586com · Cited by 66
Frenkel, B., Capparelli, C., Auken, M. V., Baran, D. T., Bryan, J., Stein, J. L., Stein, G. S., & Lian, J. B. (1997) · Endocrinology · doi:10.1210/endo.138.5.5105 · Cited by 60
Self-citationSterin‐Borda, L., Zar, C. F. D., & Borda, E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.027 · Cited by 56
Vannacci, A., Giannini, L., Passani, M. B., Felice, A. D., Pierpaoli, S., Zagli, G., Fantappiè, O., Mazzanti, R., Masini, E., & Mannaioni, P. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068635 · Cited by 47
Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_26 · Cited by 18
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“The selective CB2 agonist HU-308, but not the CB1 agonist noladine ether, attenuated ovariectomy-induced bone loss and markedly stimulated cortical thickness through the suppression of osteoclast number and stimulation of endocortical bone formation (Ofek et al., 2006).”
BackgroundInfluentialBeta-caryophyllene is a dietary cannabinoid.
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906
Self-citationTargeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Self-citationCannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Metadata
- Authors
- Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., Mechoulam, R., Zimmer, A., & Bab, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-01-09
- Volume
- 103
- Issue
- 3
- Pages
- 696-701
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1990210398
- Cited by
- 536
- References
- 48
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.